HepCAP has spent a lot of time talking about access to the newest hepatitis C treatments. This issue brief explains our concern that the high cost of medications is resulting in limited access for patients – especially those enrolled in Medicaid Managed Care plans.
If you are interested in advocating for equal access to treatment for everyone living with hepatitis C, come to our next HepCAP meeting!
HepCAP and our members are featured in these articles:
Hepatitis C drug costs leave many without care (Boston Globe, 4/9/16)
Council hears of problems from hepatitis in Philadelphia (Inquirer, 6/5/15)
Hep C: Cost in the way of a cure (Public Source, 5/24/15)
Painkiller addiction spawns new threat: hepatitis C (Inquirer, 5/8/15)
Too many unaware they carry the hep C virus (Inquirer, 4/8/15)
The rationing of hepatitis C care in America (Everyday Health, 2/18/2015)
New drugs offer hope, barriers for hepatitis C patients (Inquirer, 1/4/15)
Help on Wheels for Philly’s Public Health ‘Time Bomb,’ Hepatitis C (City Paper, 5/15/13)
May I dance with your liver? (Public’s Health Blog, 7/25/13)
Hepatitis C: A Silent Epidemic (You can help stop on Saturday) (Public’s Health Blog, 5/17/12)
HepCAP uses traditional and social media to raise awareness of hepatitis C as a serious public health issue.
Check out these videos that we’ve made!